partnership takes longer time to materialise the "seemingly untrue dream" of seeing multiple dollars, say $7 which is extremely possible in a buyout. Now if Actavis is soaring like a powerful eagle looking for its next prey to attack, ELTP is ripe for such a tasty meal for the expansion and protection of this potential billion dollar market in the pharmaceuticals industry.
Most experienced guys here know that we are weeks away(march or april) but partnership or buyout have to be announced in this period of time. So its not farfetched to say we are primed for BIG things here. But my preference for such a wealthy big boy biotech firm like Actavis, a BUYOUT resounds with many forum members here.